US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist

0.807
-0.015-1.76%

Close Nov 4 16:00 ET

0.810
+0.003+0.31%

Post 16:00 ET

137.42MMarket Cap-678P/E (TTM)

Seres Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-160.33%-39.81M

53.99%-35.24M

48.71%-117.35M

10.20%-47.5M

0.55%-59.26M

232.24%65.98M

-15.26%-76.58M

-3,521.29%-228.82M

-1.98%-52.89M

-146.64%-59.58M

Net income from continuing operations

-170.61%-32.87M

43.61%-40.13M

54.54%-113.72M

40.04%-41.25M

20.25%-47.85M

171.91%46.55M

-25.70%-71.17M

-281.46%-250.16M

-37.59%-68.8M

-187.96%-60M

Operating gains losses

---130K

---123K

--71K

---410K

---1.01M

----

Depreciation and amortization

-7.01%1.42M

11.36%1.56M

-5.82%6.24M

0.31%1.63M

-3.61%1.68M

-9.38%1.53M

-10.83%1.4M

11.47%6.63M

4.83%1.63M

17.01%1.75M

Other non cash items

-35.21%2.87M

-51.26%2.86M

118.78%15.17M

14.30%2.83M

-19.30%2.04M

158.79%4.43M

2,627.44%5.86M

70.39%6.93M

-2.37%2.48M

1,561.85%2.53M

Change In working capital

-1,036.41%-16.64M

52.67%-9.15M

-220.68%-58.98M

-442.13%-15.39M

-120.19%-22.79M

-132.84%-1.46M

-13.76%-19.34M

-144.28%-18.39M

144.87%4.5M

-119.96%-10.35M

-Change in receivables

-47.94%-11.18M

--1.26M

---8.67M

--8.18M

---9.3M

---7.56M

--0

-Change in inventory

-106.44%-11.02M

---12.33M

---29.65M

---11.12M

---13.19M

---5.34M

--0

-Change in prepaid assets

-451.40%-1.88M

44.74%4.41M

-131.16%-29.12M

-10,642.67%-31.63M

60.97%-1.08M

108.49%535K

179.25%3.04M

-2.12%-12.6M

104.09%300K

-93.67%-2.75M

-Change in payables and accrued expense

-3.83%9.68M

88.40%-2.65M

-23.09%4.26M

267.81%21.54M

-63.31%-4.51M

-20.12%10.07M

-124.83%-22.84M

-89.43%5.54M

26.04%5.86M

-106.63%-2.76M

-Change in other current liabilities

-300.59%-2.04M

-225.37%-218K

47.73%-2.2M

17.72%-562K

23.88%-1.06M

18.14%-510K

95.55%-67K

-18.39%-4.2M

49.96%-683K

-18.50%-1.39M

-Change in other working capital

-113.91%-187K

-27.39%379K

189.86%6.41M

-84.51%-1.8M

284.03%6.34M

210.53%1.34M

134.96%522K

-63.60%-7.13M

86.50%-975K

-126.96%-3.44M

Cash from discontinued investing activities

Operating cash flow

-160.33%-39.81M

53.99%-35.24M

48.71%-117.35M

10.20%-47.5M

0.55%-59.26M

232.24%65.98M

-15.26%-76.58M

-3,521.29%-228.82M

-1.98%-52.89M

-146.64%-59.58M

Investing cash flow

Cash flow from continuing investing activities

-87.62%1.3M

-102.26%-62K

-87.16%10.58M

-114.80%-877K

-104.48%-1.8M

-55.05%10.52M

-78.89%2.74M

28.62%82.43M

-55.06%5.93M

59.81%40.13M

Net PPE purchase and sale

91.97%-99K

98.48%-62K

18.80%-7.98M

74.66%-877K

-44.11%-1.8M

43.00%-1.23M

-37.90%-4.07M

-2.67%-9.82M

-119.33%-3.46M

69.53%-1.25M

Net investment purchase and sale

--0

-79.88%18.56M

--0

-54.03%11.75M

-57.25%6.81M

25.25%92.25M

-33.02%9.39M

41.69%41.38M

Cash from discontinued investing activities

Investing cash flow

-87.62%1.3M

-102.26%-62K

-87.16%10.58M

-114.80%-877K

-104.48%-1.8M

-55.05%10.52M

-78.89%2.74M

28.62%82.43M

-55.06%5.93M

59.81%40.13M

Financing cash flow

Cash flow from continuing financing activities

231.72%18.76M

-44.67%71.71M

39.85%6.43M

-98.53%1.44M

44,651.54%58.18M

-78.93%5.66M

10,901.87%129.6M

689.36%4.6M

15,996.39%98.03M

Net issuance payments of debt

----

96.58%50.52M

--0

----

2,810.86%25.7M

--0

Net common stock issuance

--0

334.28%18.41M

-82.05%18.16M

450.43%6.43M

--0

--7.49M

--4.24M

--101.17M

--1.17M

--100M

Proceeds from stock option exercised by employees

--0

-75.09%353K

10.71%3.03M

--0

10.49%1.44M

29.23%168K

23.32%1.42M

28.65%2.74M

-10.71%150K

114.45%1.31M

Cash from discontinued financing activities

Financing cash flow

--0

231.72%18.76M

-44.67%71.71M

39.85%6.43M

-98.53%1.44M

44,651.54%58.18M

-78.93%5.66M

10,901.87%129.6M

689.36%4.6M

15,996.39%98.03M

Net cash flow

Beginning cash position

16.10%119.61M

-20.48%136.15M

-8.93%171.22M

-16.61%178.1M

76.07%237.71M

-36.16%103.03M

-8.93%171.22M

62.00%188M

-6.10%213.58M

82.45%135.01M

Current changes in cash

-128.59%-38.51M

75.75%-16.54M

-108.91%-35.07M

1.00%-41.95M

-175.86%-59.61M

610.76%134.68M

-156.11%-68.19M

-123.33%-16.79M

-7.38%-42.37M

-48.80%78.58M

Effect of exchange rate changes

----

300.00%2K

--0

150.00%1K

----

0.00%-1K

200.00%1K

---2K

End cash Position

-65.88%81.11M

16.10%119.61M

-20.48%136.15M

-16.61%178.1M

76.07%237.71M

-36.16%103.03M

-8.93%171.22M

-6.10%213.58M

Free cash flow

-161.64%-39.91M

56.23%-35.3M

47.48%-125.33M

14.16%-48.38M

-0.37%-61.05M

224.38%64.75M

-16.22%-80.65M

-8,191.77%-238.64M

-5.45%-56.35M

-149.19%-60.83M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-160.33%-39.81M	53.99%-35.24M	48.71%-117.35M	10.20%-47.5M	0.55%-59.26M	232.24%65.98M	-15.26%-76.58M	-3,521.29%-228.82M	-1.98%-52.89M	-146.64%-59.58M
Net income from continuing operations	-170.61%-32.87M	43.61%-40.13M	54.54%-113.72M	40.04%-41.25M	20.25%-47.85M	171.91%46.55M	-25.70%-71.17M	-281.46%-250.16M	-37.59%-68.8M	-187.96%-60M
Operating gains losses	---130K	---123K	--71K	---410K	---1.01M	----	----	----	----	----
Depreciation and amortization	-7.01%1.42M	11.36%1.56M	-5.82%6.24M	0.31%1.63M	-3.61%1.68M	-9.38%1.53M	-10.83%1.4M	11.47%6.63M	4.83%1.63M	17.01%1.75M
Other non cash items	-35.21%2.87M	-51.26%2.86M	118.78%15.17M	14.30%2.83M	-19.30%2.04M	158.79%4.43M	2,627.44%5.86M	70.39%6.93M	-2.37%2.48M	1,561.85%2.53M
Change In working capital	-1,036.41%-16.64M	52.67%-9.15M	-220.68%-58.98M	-442.13%-15.39M	-120.19%-22.79M	-132.84%-1.46M	-13.76%-19.34M	-144.28%-18.39M	144.87%4.5M	-119.96%-10.35M
-Change in receivables	-47.94%-11.18M	--1.26M	---8.67M	--8.18M	---9.3M	---7.56M	--0	--0	--0	--0
-Change in inventory	-106.44%-11.02M	---12.33M	---29.65M	---11.12M	---13.19M	---5.34M	--0	--0	--0	--0
-Change in prepaid assets	-451.40%-1.88M	44.74%4.41M	-131.16%-29.12M	-10,642.67%-31.63M	60.97%-1.08M	108.49%535K	179.25%3.04M	-2.12%-12.6M	104.09%300K	-93.67%-2.75M
-Change in payables and accrued expense	-3.83%9.68M	88.40%-2.65M	-23.09%4.26M	267.81%21.54M	-63.31%-4.51M	-20.12%10.07M	-124.83%-22.84M	-89.43%5.54M	26.04%5.86M	-106.63%-2.76M
-Change in other current liabilities	-300.59%-2.04M	-225.37%-218K	47.73%-2.2M	17.72%-562K	23.88%-1.06M	18.14%-510K	95.55%-67K	-18.39%-4.2M	49.96%-683K	-18.50%-1.39M
-Change in other working capital	-113.91%-187K	-27.39%379K	189.86%6.41M	-84.51%-1.8M	284.03%6.34M	210.53%1.34M	134.96%522K	-63.60%-7.13M	86.50%-975K	-126.96%-3.44M
Cash from discontinued investing activities
Operating cash flow	-160.33%-39.81M	53.99%-35.24M	48.71%-117.35M	10.20%-47.5M	0.55%-59.26M	232.24%65.98M	-15.26%-76.58M	-3,521.29%-228.82M	-1.98%-52.89M	-146.64%-59.58M
Investing cash flow
Cash flow from continuing investing activities	-87.62%1.3M	-102.26%-62K	-87.16%10.58M	-114.80%-877K	-104.48%-1.8M	-55.05%10.52M	-78.89%2.74M	28.62%82.43M	-55.06%5.93M	59.81%40.13M
Net PPE purchase and sale	91.97%-99K	98.48%-62K	18.80%-7.98M	74.66%-877K	-44.11%-1.8M	43.00%-1.23M	-37.90%-4.07M	-2.67%-9.82M	-119.33%-3.46M	69.53%-1.25M
Net investment purchase and sale	--0	--0	-79.88%18.56M	--0	--0	-54.03%11.75M	-57.25%6.81M	25.25%92.25M	-33.02%9.39M	41.69%41.38M
Cash from discontinued investing activities
Investing cash flow	-87.62%1.3M	-102.26%-62K	-87.16%10.58M	-114.80%-877K	-104.48%-1.8M	-55.05%10.52M	-78.89%2.74M	28.62%82.43M	-55.06%5.93M	59.81%40.13M
Financing cash flow
Cash flow from continuing financing activities	0	231.72%18.76M	-44.67%71.71M	39.85%6.43M	-98.53%1.44M	44,651.54%58.18M	-78.93%5.66M	10,901.87%129.6M	689.36%4.6M	15,996.39%98.03M
Net issuance payments of debt	----	----	96.58%50.52M	--0	--0	----	----	2,810.86%25.7M	--0	--0
Net common stock issuance	--0	334.28%18.41M	-82.05%18.16M	450.43%6.43M	--0	--7.49M	--4.24M	--101.17M	--1.17M	--100M
Proceeds from stock option exercised by employees	--0	-75.09%353K	10.71%3.03M	--0	10.49%1.44M	29.23%168K	23.32%1.42M	28.65%2.74M	-10.71%150K	114.45%1.31M
Cash from discontinued financing activities
Financing cash flow	--0	231.72%18.76M	-44.67%71.71M	39.85%6.43M	-98.53%1.44M	44,651.54%58.18M	-78.93%5.66M	10,901.87%129.6M	689.36%4.6M	15,996.39%98.03M
Net cash flow
Beginning cash position	16.10%119.61M	-20.48%136.15M	-8.93%171.22M	-16.61%178.1M	76.07%237.71M	-36.16%103.03M	-8.93%171.22M	62.00%188M	-6.10%213.58M	82.45%135.01M
Current changes in cash	-128.59%-38.51M	75.75%-16.54M	-108.91%-35.07M	1.00%-41.95M	-175.86%-59.61M	610.76%134.68M	-156.11%-68.19M	-123.33%-16.79M	-7.38%-42.37M	-48.80%78.58M
Effect of exchange rate changes	----	----	300.00%2K	--0	150.00%1K	----	----	0.00%-1K	200.00%1K	---2K
End cash Position	-65.88%81.11M	16.10%119.61M	-20.48%136.15M	-20.48%136.15M	-16.61%178.1M	76.07%237.71M	-36.16%103.03M	-8.93%171.22M	-8.93%171.22M	-6.10%213.58M
Free cash flow	-161.64%-39.91M	56.23%-35.3M	47.48%-125.33M	14.16%-48.38M	-0.37%-61.05M	224.38%64.75M	-16.22%-80.65M	-8,191.77%-238.64M	-5.45%-56.35M	-149.19%-60.83M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data